» Articles » PMID: 21471230

Intercompartmental Recombination of HIV-1 Contributes to Env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors

Abstract

HIV-1 circulates within an infected host as a genetically heterogeneous viral population. Viral intrahost diversity is shaped by substitutional evolution and recombination. Although many studies have speculated that recombination could have a significant impact on viral phenotype, this has never been definitively demonstrated. We report here phylogenetic and subsequent phenotypic analyses of envelope genes obtained from HIV-1 populations present in different anatomical compartments. Assessment of env compartmentalization from immunologically discrete tissues was assessed utilizing a single genome amplification approach, minimizing in vitro-generated artifacts. Genetic compartmentalization of variants was frequently observed. In addition, multiple incidences of intercompartment recombination, presumably facilitated by low-level migration of virus or infected cells between different anatomic sites and coinfection of susceptible cells by genetically divergent strains, were identified. These analyses demonstrate that intercompartment recombination is a fundamental evolutionary mechanism that helps to shape HIV-1 env intrahost diversity in natural infection. Analysis of the phenotypic consequences of these recombination events showed that genetic compartmentalization often correlates with phenotypic compartmentalization and that intercompartment recombination results in phenotype modulation. This represents definitive proof that recombination can generate novel combinations of phenotypic traits which differ subtly from those of parental strains, an important phenomenon that may have an impact on antiviral therapy and contribute to HIV-1 persistence in vivo.

Citing Articles

Multiple third-generation recombinants formed by CRF55_01B and CRF07_BC in newly diagnosed HIV-1 infected patients in Shenzhen city, China.

Jiao Y, An M, Zhang N, Zhang H, Zheng C, Chen L Virol J. 2024; 21(1):306.

PMID: 39593171 PMC: 11590514. DOI: 10.1186/s12985-024-02563-z.


Implications of the 375W mutation for HIV-1 tropism and vaccine development.

Verdejo-Torres O, Vargas-Pavia T, Fatima S, Clapham P, Duenas-Decamp M J Virol. 2024; 98(1):e0152223.

PMID: 38169306 PMC: 10804988. DOI: 10.1128/jvi.01522-23.


Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.

Botha J, Byott M, Spyer M, Grant P, Gartner K, Chen W Viruses. 2023; 15(9).

PMID: 37766218 PMC: 10536450. DOI: 10.3390/v15091811.


Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection.

Mandizvo T, Gumede N, Ndlovu B, Ndlovu S, Mann J, Chopera D J Virol. 2022; 96(24):e0127022.

PMID: 36453881 PMC: 9769376. DOI: 10.1128/jvi.01270-22.


Single Genome Sequencing of Expressed and Proviral HIV-1 Envelope Glycoprotein 120 () and Genes.

Nolan D, Lamers S, Rose R, Dollar J, Salemi M, McGrath M Bio Protoc. 2021; 7(12):e2334.

PMID: 34541092 PMC: 8410429. DOI: 10.21769/BioProtoc.2334.


References
1.
Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D . Diversity considerations in HIV-1 vaccine selection. Science. 2002; 296(5577):2354-60. DOI: 10.1126/science.1070441. View

2.
Liu J, Bartesaghi A, Borgnia M, Sapiro G, Subramaniam S . Molecular architecture of native HIV-1 gp120 trimers. Nature. 2008; 455(7209):109-13. PMC: 2610422. DOI: 10.1038/nature07159. View

3.
Peters P, Bhattacharya J, Hibbitts S, Dittmar M, Simmons G, Bell J . Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an.... J Virol. 2004; 78(13):6915-26. PMC: 421670. DOI: 10.1128/JVI.78.13.6915-6926.2004. View

4.
Levy D, Aldrovandi G, Kutsch O, Shaw G . Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A. 2004; 101(12):4204-9. PMC: 384719. DOI: 10.1073/pnas.0306764101. View

5.
McClure P, Curran R, Boneham S, Ball J . A polymerase chain reaction method for the amplification of full-length envelope genes of HIV-1 from DNA samples containing single molecules of HIV-1 provirus. J Virol Methods. 2000; 88(1):73-80. DOI: 10.1016/s0166-0934(00)00179-8. View